Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018226245) DEVICES AND METHODS FOR ENHANCED SKIN PERFORATION FOR CONTINUOUS GLUCOSE MONITORING
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/226245 International Application No.: PCT/US2017/036854
Publication Date: 13.12.2018 International Filing Date: 09.06.2017
IPC:
A61B 5/00 (2006.01) ,A61B 5/145 (2006.01) ,A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
5
Measuring for diagnostic purposes; Identification of persons
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
5
Measuring for diagnostic purposes; Identification of persons
145
Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
ARKAL, INC. [US/US]; 3353 Colonna Avenue San Jose, California 95148, US
Inventors:
JINA, Arvind N.; US
TAMADA, Janet; US
DESAI, Shashi; US
LEE, Jonathan; US
Agent:
BAGADE, Sanjay S.; US
LEVINE, David A.; US
HAN, Johney U.; US
GALLAGHER, Laura L.; US
XU, Daniel X.; US
MCADAMS, Grant; US
Priority Data:
Title (EN) DEVICES AND METHODS FOR ENHANCED SKIN PERFORATION FOR CONTINUOUS GLUCOSE MONITORING
(FR) DISPOSITIFS ET MÉTHODES POUR UNE PERFORATION AMÉLIORÉE DE LA PEAU POUR UNE SURVEILLANCE CONTINUE DU GLUCOSE
Abstract:
(EN) The efficacy of tissue piercing elements in the area of transdermal drug delivery is well-documented. Multiple studies have shown that enhancement of skin permeation via creation of microscopic pores in the stratum corneum can greatly improve the delivery rates of drugs. However, skin perforation with tissue piercing elements is not the only factor affecting the rate of drug transport. Other factors including such as the formulation of the drug and rate of closure of the micropores closure also need to be considered. Similarly micro tissue piercing elements have been used with less success by several workers for continuous glucose monitoring.
(FR) L'efficacité d'éléments de perforation de tissu dans la zone d'administration de médicament transdermique est bien documentée. De multiples études ont montré que l'amélioration de la perméation de la peau par la création de pores microscopiques dans la couche cornée peut améliorer considérablement les taux d'administration de médicaments. Cependant, la perforation de la peau avec des éléments de perforation de tissu n'est pas le seul facteur affectant le taux de transport de médicament. D'autres facteurs tels que la formulation du médicament et le taux de fermeture de la fermeture des micropores doivent également être considérés. De même, des éléments de perforation de micro-tissus ont été utilisés avec moins de succès par plusieurs professionnels pour une surveillance continue du glucose.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)